Sebastian Janka

Dr Susanne Schießer has been practicing law since 1997, specialising in commercial and residential tenancy law. She focuses on sectors such as retail, logistics, research and light industrial facilities, healthcare properties, residential portfolios, and hotels. Dr Schießer also advises on FM contracts, brokerage law, land law, and heritable building rights, and represents clients in courts throughout Germany. She regularly gives lectures at client events and teaches at Biberach U...

Lawyer Senior Asia Counsel

Ralf Euling has specialised exclusively in private construction and architectural law, commercial tenancy law, property law, and public procurement law since 1994. He primarily advises private clients and public sector entities operating under private law, including architects, engineers, project developers, and investors, on all aspects of private construction law, commercial tenancy law, and public procurement law. His expertise includes drafting and negotiating contracts with general contr...

Dr Frank Thiäner is a partner at POELLATH in Munich. Frank advises shareholders, investors and companies on M&A transactions. His focus is on private equity, family-owned enterprises and cross-border transactions. He also advises on venture capital transactions and succession planning. His clients include well-known German and international private equity funds, owners of medium-sized companies and private investors. He is one of the founders of the Munich M&A Forum e.V., served ...

Ludwig Zesch advises national and international private equity funds, corporate borrowers, debt funds and financial institutions on a range of complex domestic and cross-border financings. His practice includes acquisition finance, direct lending, leveraged buyouts and corporate financing. Ludwig has particular experience handling significant acquisition financings involving a range of debt structures, including unitranche/super senior structures. Prior to joining McDermott, he worked for oth...

Rainer Schaaf, LL.M., partner, is an expert for insolvency law specialized in legal support of distressed M&A deals. He has also special expertise in asserting and defending insolvency claims as well as supporting restructuring procedures. In addition, he has extensive experience in banking and finance law as well as in commercial law. He is a member of the steering committee of the work group Reorganisation, Restructuring and Insolvency of the Juristische Gesellschaft Mittelfranken zu N&...

Tobias Jäger is a partner at POELLATH in Munich. At POELLATH, Tobias became an expert on classic M&A/private equity and venture capital transactions and has continuously expanded his practice in the restructuring and reorganization of companies. Today, he heads the firm‘s restructuring and bankruptcy practice. He finds reliable solutions on a legally substantiated basis for special situations, joint ventures and distressed transactions and has extensive experience in corporate,...

Dr Nico Fischer is a partner at POELLATH in Munich. His core areas are national and international tax law, general tax planning and structuring with a focus on private equity and M&A. In addition, he advises national and international private equity houses as well as German carry holders on German tax issues. Nico regularly publishes articles on tax topics in relevant professional media and passes on his expertise as a lecturer at the University of Muenster in the Master’s program i...

Stephan Rau is Managing Shareholder of Greenberg Traurig’s Munich office and Chair of the firm’s European Healthcare Practice. He focuses in advising on private equity/ M&A transactions, and regulatory in the healthcare and life sciences sectors. His clients include private equity and strategic investors, healthcare service providers, pharmaceutical companies, medical device manufacturers, and university institutions. Due to his experience, Stephan Rau is recognized as a leadi...

Markus Engelhard is active in all fields of life sciences, pharmacology, and biotechnology, having a particular focus on therapeutic biomolecules and pharmaceutically active agents. His clients include start-up companies, small and medium-sized enterprises, multinational corporations, universities, and academic research institutions. He supports them in acquiring and enforcing intellectual property rights, building up patent portfolios, and representing them in opposition, invalidation, and i...